Stockscreener 앱 받기
24.01
0.91%
-0.22
Omada Health Inc 주식(OMDA)의 최신 뉴스
Omada Health's (OMDA) Sell (D) Rating Reaffirmed at Weiss Ratings - MarketBeat
Omada Health’s Digital Care Bet Outpaces Wall Street Expectations - Finimize
Omada Health, Inc. (NASDAQ:OMDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Omada Health (NASDAQ:OMDA) Trading Up 7.6%Time to Buy? - MarketBeat
United States Digital Therapeutics Market Trends & Forecast | - openPR.com
Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients - HIT Consultant
Omada Health Launches 'Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting - The Manila Times
Beyond Calorie Counting: Omada Health's New AI Meal Map Revolutionizes Digital Nutrition Guidance - Stock Titan
Omada Health, Inc. (NASDAQ:OMDA) Receives $24.50 Consensus PT from Analysts - MarketBeat
Omada Health: Multiple Indicators Convince Me The Growth Outlook Remains Healthy - Seeking Alpha
Omada Health (NASDAQ:OMDA) Stock Price Down 5.9%Here's What Happened - MarketBeat
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Baird R W - MarketBeat
Omada simplifies and accelerates IGA deployment while lowering total cost of ownership - Yahoo Finance
United States 7MM Digital Therapeutics for Diabetes Market - openPR.com
How Does Omada Health Stack Up After a 26% Share Price Surge? - Yahoo Finance
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions - Yahoo Finance
Just 0.8% Weight Change: Omada Health's Groundbreaking Study Challenges Post-GLP-1 Weight Regain Assumptions - Stock Titan
Omada Health Develops Threat Model to Assess AI Risks in Healthcare - geneonline.com
Omada Health, Inc.(NasdaqGS: OMDA) added to NASDAQ Composite Index - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating By Investing.com - Investing.com Australia
Omada Health shares fall 2.23% intraday after Baird initiates coverage with a Neutral rating and $24 price target. - AInvest
Baird Initiates Omada Health at Neutral With $24 Price Target - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating - Investing.com
Baird Initiates Omada Health(OMDA.US) With Hold Rating, Announces Target Price $24 - 富途牛牛
Heartflow, Inc. shares rise 2.21% premarket after new research from Omada Health demonstrates lower healthcare utilization and spending for patients using virtual physical therapy programs. - AInvest
Omada Health announce research on cost savings of virtual physical therapy - TipRanks
Omada Health Study Shows Virtual PT Saves on Medical Care and Costs. - AInvest
Omada Health Study Finds Virtual Physical Therapy Saves Significant Costs for Musculoskeletal Conditions - AInvest
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy - Yahoo Finance
$1,000+ Per Patient: Omada's Virtual Physical Therapy Outperforms Traditional Care in Major Cost Study - Stock Titan
Omada Health shares fall 1.75% premarket ahead of senior management's participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Heartflow, Inc. shares rise 2.87% premarket after Omada Health's senior management participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health shares rise 3.31% intraday after announcing participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health to Participate in Upcoming Investor Conference - Yahoo Finance
Virtual Healthcare Leader Omada Health to Present at Morgan Stanley's 23rd Global Healthcare Conference - Stock Titan
Omada Health, Inc. (NASDAQ:OMDA) Receives $24.57 Average PT from Brokerages - MarketBeat
Healthcare Analysts Bullish on CSL, UnitedHealth, and Omada Health - AInvest
Omada Health stock rises on market debut - MSN
U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Visana Health Appoints Chief Commercial Officer to Drive New Growth - Business Wire
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Barclays raises Omada Health PT to $24, maintains Overweight rating. - AInvest
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
8.35%
1.76%
자본화:
|
볼륨(24시간):